Komori
Dividends4554Fuji Pharma Co.,Ltd.Pharmaceuticals

Notice Concerning Dividend from Surplus (Increase in Dividend)

The year-end dividend for the fiscal year ending September 2026 was set at ¥29 per share, an increase of ¥3 from the previous forecast of ¥26. The annual dividend was also set at ¥52, up from ¥45.50 in the previous fiscal year.

Worth reading
66In focus
0–100. This measures how worthwhile something is to read, not how good or bad the company is.
Direction
Improvement
Direction inferred from the company’s description.
Scale
3
¥ per share
Wording
Conditional
How definitive the wording is.

Dividend per share

Fiscal year ending September 2026
52YenRevised annual dividend per sharePrevious forecast ¥26, change ¥+26(+11.5%)
Previous-period resultsPrevious forecastAfter revision

Each vertical step represents one dividend payment, and the total height of the accumulated steps represents the annual dividend for the period. For periods showing only the annual amount, the payment breakdown is not provided, so only the end point is plotted.

Dividend per shareYen¥26→¥29+11.5%
Total dividendsTotal amount payable to all shareholdersAmount 624 Millions of yen→Amount 758 Millions of yen
Whether Submission to the General Meeting of Shareholders Is RequiredScheduled for submission to the general meeting of shareholders
Record date30 September 2026
Effective date21 December 2026

The record date is the cutoff date for determining which persons listed in the shareholder register on that date are entitled to receive dividends.Payments begin on the effective date.

Payout ratioFigure 30 % / Subject Guideline based on operating income after tax, excluding special factorsThe percentage of earnings paid out as dividends.
Source of dividendsRetained earningsThe source of dividend payments. Depending on the type of surplus, the dividend may be paid from earned profits or may be closer to a return of capital.
Dividend policy

The company will make profit distributions based on consolidated results and pay stable and consistent dividends, using a payout ratio of 30% based on operating income after tax, excluding special factors, as a guideline.

Dividend per share
ItemDetails
Dividend per share26 Yen → 29 Yen(+11.5%)
Total Annual DividendsNot disclosed → 52 Yen
Previous-period results (per share)Interim 20 Yen / End of period 25.5 Yen / Annual 45.5 Yen
Total dividendsAmount 624 Millions of yen → Amount 758 Millions of yen
Record date30 September 2026
Effective date21 December 2026
Source of dividendsRetained earnings
Payout ratioFigure 30 % / Subject Guideline based on operating income after tax, excluding special factors
Dividend policyThe company will make profit distributions based on consolidated results and pay stable and consistent dividends, using a payout ratio of 30% based on operating income after tax, excluding special factors, as a guideline.
Whether Submission to the General Meeting of Shareholders Is RequiredScheduled for submission to the general meeting of shareholders
Fiscal Period CoveredFiscal year ending September 2026
Items this document does not state (1)
Breakdown of Regular, Commemorative and Special Dividends

These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.

The reasons the company gives

The company's own explanation, not something inferred from the numbers.

Because full-year results for the fiscal year ending September 2026 exceeded expectations. The dividend policy is to make profit distributions based on consolidated results and pay stable and consistent dividends, using a payout ratio of 30% based on operating income after tax, excluding special factors, as a guideline.

How to read this page

This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.
Notice Concerning Dividend from Surplus (Increase in Dividend) | Fuji Pharma Co.,Ltd. (4554) timely disclosure | Komori